Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2022. Start Trial.
Date Value
June 30, 2026 -84.92M
March 31, 2026 -80.57M
December 31, 2025 -58.34M
September 30, 2025 -79.73M
June 30, 2025 -89.27M
March 31, 2025 -88.21M
December 31, 2024 -103.62M
September 30, 2024 -103.56M
Date Value
June 30, 2024 -109.24M
March 31, 2024 -126.17M
December 31, 2023 -133.21M
September 30, 2023 -125.74M
June 30, 2023 -122.38M
March 31, 2023 -106.02M
December 31, 2022 -83.04M
September 30, 2022 -73.80M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Insulet Corp. 265.70M
Abbott Laboratories 7.824B
Globus Medical, Inc. 750.84M
Stryker Corp. 4.702B
Baxter International, Inc. 812.00M